Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer
ALK fusion oncogene positive Non-Small Cell Lung Cancer (NSCLC) represents a distinct and significant subset of lung cancer characterized by a genetic mutation that drives abnormal cell growth in the lungs. Accounting for 3-7% of NSCLC cases, this subtype predominantly affects younger individuals and non-smokers, presenting unique clinical features and treatment challenges.